Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

Saved in:
Bibliographic Details
Title: Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.
Authors: Roshani S; Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Boekel NB; Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Rademakers SE; Department of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, The Netherlands., Roesink J; Department of Hematology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands., Schippers MGA; Department of Radiation Oncology, Instituut Verbeeten, Brugstraat 10, Tilburg, 5042 SB, The Netherlands., Ta BDP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, 9700 RB, The Netherlands., Zijlstra JM; Department of Hematology, Amsterdam UMC, location VUMC, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands., Schinagl DAX; Department of Radiation Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, Nijmegen, 6525 GA, The Netherlands., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Michelangelolaan 2, Eindhoven, 5623 EJ, The Netherlands., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Koningstraat 1, Enschede, 7512 KZ, The Netherlands., Schimmel EC; Department of Radiotherapy, Radiotherapiegroep, Wagnerlaan 47, Arnhem, 6815 AD, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Reinier de Graafweg 5, Delft, 2625 AD, The Netherlands., Daniels LA; Department of Radiation Oncology, Amsterdam UMC, location AMC, Meibergdreef 9, Amsterdam, The Netherlands., Böhmer LH; Department of Hematology, Haga Teaching Hospital, Els Borst-Eilersplein 275, Den Haag, 2545 AA, The Netherlands., Muller K; Department of Radiotherapy, Radiotherapiegroep, Nico Bolkesteinlaan 85, Deventer, 7416 SE, The Netherlands., Koene HR; Department of Hematology, St Antonius hospital, Koekoekslaan 1, Nieuwegein, 3435 CM, The Netherlands., Te Boome LCJ; Department of Hematology, Haaglanden Medical Center, Lijnbaan 32, Den Haag, 2512 VA, The Netherlands., Bilgin YM; Department of Internal Medicine, Adrz, 's-Gravenpolderseweg 114, Goes, 4462 RA, The Netherlands., De Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Albert Schweitzerplaats 25, Dordrecht, 3318 AT, The Netherlands., Janus CPM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2026 Mar 23. Date of Electronic Publication: 2026 Mar 23.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1460-2105
DOI:10.1093/jnci/djag090